[1] Atkinson H, Chalmers R. Delivering the goods: viral and nonviral gene therapy systems and the inherent limits on cargo DNA and internal sequences[J]. Genetica, 2010, 138(5): 485-498.
[2] Bainbridge J W, Smith A J, Barker S S, et al. Effect of gene therapy on visual function in lebers congenital amaurosis[J]. New England Journal of Medicine, 2008, 358(21): 2231-2239.
[3] AlDosari M S, Gao X. Nonviral gene delivery: principle, limitations, and recent progress[J]. The AAPS Journal, 2009, 11(4): 671-681.
[4] Phillips J E, Gersbach C A, García A J. Virus based gene therapy strategies for bone regeneration[J]. Biomaterials, 2007, 28(2): 211-229.
[5] Daya S, Berns K I. Gene therapy using adeno associated virus vectors[J]. Clinical Microbiology Reviews, 2008, 21(4): 583-593.
[6] Mohyeldin A, Chiocca E A. Gene and viral therapy for glioblastoma: a review of clinical trials and future directions[J]. The Cancer Journal, 2012, 18(1): 82-88.
[7] Gao S, Chen J, Dong L, et al. Targeting delivery of oligonucleotide and plasmid DNA to hepatocyte via galactosylated chitosan vector[J]. European Journal of Pharmaceutics and Biopharmaceutics, 2005, 60(3): 327-334.
[8] Chowdhury E, Maruyama A, Kano A, et al. Ph sensing nano crystals of carbonate apatite: effects on intracellular delivery and release of DNA for efficient expression into mammalian cells[J]. Gene, 2006, 376(1): 87-94.
[9] Wong S Y, Pelet J M, Putnam D. Polymer systems for gene delivery: past, present, and future[J]. Progress in Polymer Science, 2007, 32(8): 799-837.
[10] Bianco A, Kostarelos K, Prato M. Applications of carbon nanotubes in drug delivery[J]. Current Opinion in Chemical Biology, 2005, 9(6): 674-679.
[11] Uskokovi c V, Uskokovi c D P. Nanosized hydroxyapatite and other calcium phosphates: chemistry of formation and application as drug and gene delivery agents[J]. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2011, 96(1): 152-191.